Journal of Controlled Release 2021

3 papers
In 2021, research published in the Journal of Controlled Release focused significantly on advanced delivery systems for oncology. Key themes included the regulation of the tumor microenvironment and the application of biomimetic strategies to treat breast cancer metastasis. Studies also investigated the use of inorganic platforms, such as MoO3-x nanosheets, for combined photodynamic and photothermal therapies (PDT/PTT) activated by near-infrared lasers. Additional research explored immunotherapy through the development of "cytokine-microfactories" designed to recruit dendritic cells and deliver tumor antigens via gap junctions. Prolific contributors to these developments included Haibao Peng, Lixin Wang, Nianping Feng, and Ping Wang. These publications highlight a trend toward integrating nanotechnology with biological signaling mechanisms to enhance therapeutic targeting. The year's output reflects an emphasis on multifunctional nanocarriers and specialized delivery platforms for complex disease management.

Papers

Title
“Cytokine-microfactories” recruit DCs and deliver tumor antigens via gap junctions for immunotherapy
MoO3-x nanosheets-based platform for single NIR laser induced efficient PDT/PTT of cancer
Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis